Pharvaris Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	989	1,150	380	477
Market Cap Growth	248.01%	202.44%	-20.27%	-
Enterprise Value	587	715	208	239
PE Ratio	-	-10.26	-4.68	-9.82
PB Ratio	2.53	2.69	2.39	2.05
P/FCF Ratio	-9.45	-11.11	-5.31	-9.38
P/OCF Ratio	-9.46	-11.12	-5.32	-9.41
EV/EBITDA Ratio	-4.84	-6.66	-2.26	-3.89
EV/EBIT Ratio	-4.83	-6.64	-2.26	-3.89
EV/FCF Ratio	-5.46	-6.91	-2.91	-4.70
Debt / Equity Ratio	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00	-0.01	0.00
Debt / FCF Ratio	0.00	0.00	-0.01	-0.01
Interest Coverage	-123.96	-33.27	-	-
Return on Equity (ROE)	-39.70%	-48.00%	-42.70%	-19.50%
Return on Assets (ROA)	-37.40%	-44.60%	-39.20%	-18.80%
Return on Capital (ROIC)	-28.98%	-25.22%	-57.93%	-26.38%
Earnings Yield	-11.69%	-9.75%	-21.36%	-10.19%
FCF Yield	-10.16%	-9.00%	-18.83%	-10.66%
Buyback Yield / Dilution	-21.30%	-21.30%	-1.99%	-8.55%
Total Shareholder Return	-21.30%	-21.30%	-1.99%	-8.55%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).